Literature DB >> 25028445

Morphology of susceptibility vessel sign predicts middle cerebral artery recanalization after intravenous thrombolysis.

Shenqiang Yan1, Haitao Hu1, Zhenghao Shi1, Xuting Zhang1, Sheng Zhang1, David S Liebeskind1, Min Lou2.   

Abstract

BACKGROUND AND
PURPOSE: We aimed to evaluate the predictive value of susceptibility vessel sign (SVS) burden and morphology in middle cerebral artery recanalization.
METHODS: We retrospectively examined clinical and imaging data from 72 consecutive patients with acute ischemic stroke with middle cerebral artery occlusion and examined the association of recanalization with SVS length and shape.
RESULTS: None of the patients with a middle cerebral artery SVS >20 mm in length achieved recanalization. For patients with a relatively short SVS (length <20 mm), irregular shape was a strong independent predictor for no recanalization (odds ratio, 6.891; 95% confidence interval, 1.441-32.950; P=0.016).
CONCLUSIONS: Irregular shape and long length (>20 mm) of SVS decrease the potential to recanalize the occluded middle cerebral artery with intravenous thrombolysis.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  magnetic resonance imaging; middle cerebral artery; stroke; thrombolytic therapy

Mesh:

Year:  2014        PMID: 25028445     DOI: 10.1161/STROKEAHA.114.006144

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  7 in total

Review 1.  Stroke Research in China over the Past Decade: Analysis of NSFC Funding.

Authors:  Lijun Zhu; Dongsheng He; Lijuan Han; Heqi Cao
Journal:  Transl Stroke Res       Date:  2015-06-05       Impact factor: 6.829

2.  Susceptibility vessel sign predicts poor clinical outcome for acute stroke patients untreated by thrombolysis.

Authors:  Huiqin Liu; Wenli Mei; Yue Huang; Yongli Li; Zuzhi Chen; Dongdong Li; Hong Ye; Jiewen Zhang
Journal:  Exp Ther Med       Date:  2017-09-22       Impact factor: 2.447

3.  R2* Map by IDEAL IQ for Acute Cerebral Infarction: Compared with Susceptibility Vessel Sign on T2*-Weighted Imaging.

Authors:  Yuki Shinohara; Ayumi Kato; Eijiro Yamashita; Toshihide Ogawa
Journal:  Yonago Acta Med       Date:  2016-09-12       Impact factor: 1.641

4.  Thrombus Length Estimation on Delayed Gadolinium-Enhanced T1.

Authors:  Shenqiang Yan; Qingmeng Chen; Mengjun Xu; Jianzhong Sun; David S Liebeskind; Min Lou
Journal:  Stroke       Date:  2016-01-14       Impact factor: 7.914

5.  Characteristic Signs on T2*-Based Imaging and Their Relationship with Results of Reperfusion Therapy for Acute Ischemic Stroke: A Systematic Review and Evidence to Date.

Authors:  Hak Cheol Ko; Chang-Woo Ryu; Seong Jong Yun; Jun Seok Koh; Hee Sup Shin; Eui Jong Kim
Journal:  Neurointervention       Date:  2018-08-31

Review 6.  Susceptibility-weighted Imaging in Thrombolytic Therapy of Acute Ischemic Stroke.

Authors:  Lin Li; Ming-Su Liu; Guang-Qin Li; Yang Zheng; Tong-Li Guo; Xin Kang; Mao-Ting Yuan
Journal:  Chin Med J (Engl)       Date:  2017-10-20       Impact factor: 2.628

Review 7.  ASL and susceptibility-weighted imaging contribution to the management of acute ischaemic stroke.

Authors:  Sébastien Verclytte; Olivier Fisch; Lucie Colas; Olivier Vanaerde; Manuel Toledano; Jean-François Budzik
Journal:  Insights Imaging       Date:  2016-11-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.